Sanofi $750m acquisition gives it edge in flu vacccine market
Biotech’s Flublok is only FDA-approved cell-based flu jab
X
Sanofi $750m acquisition gives it edge in flu vacccine market
https://pharmaphorum.com/news/sanofi-buys-vaccine-biotech-protein-sciences/
